home / stock / ifrx / ifrx news


IFRX News and Press, InflaRx N.V. From 04/12/23

Stock Information

Company Name: InflaRx N.V.
Stock Symbol: IFRX
Market: NASDAQ
Website: inflarx.de

Menu

IFRX IFRX Quote IFRX Short IFRX News IFRX Articles IFRX Message Board
Get IFRX Alerts

News, Short Squeeze, Breakout and More Instantly...

IFRX - Altamira, Arrowhead top healthcare gainers; Cutera, Innovative Eyewear among losers

2023-04-12 10:03:10 ET Gainers: Altamira Therapeutics ( CYTO ) +74% . Arrowhead Pharmaceuticals ( ARWR ) +11% . Procaps Group ( PROC ) +11% . Tempest Therapeutics ( TPST ) +11% . Meihua International Medical Technologies ( MHUA )...

IFRX - InflaRx prices $40M offering

2023-04-12 02:57:39 ET Clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system,InflaRx N.V. ( NASDAQ: IFRX ) priced its underwritten public offering of ~9.42M shares at an offering price of $4.25 per share. ...

IFRX - InflaRx Announces Pricing of $40 Million Public Offering of Ordinary Shares

JENA, Germany, April 12, 2023 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, announced today the pricing of its underwritten public offering of ...

IFRX - InflaRx announces public offering of ordinary shares

2023-04-11 16:23:04 ET Shares of German biotech InflaRx N.V. ( NASDAQ: IFRX ) held steady in the post-market trading even after the company announced the launch of an underwritten public offering of its ordinary shares. The company said the offering is subject to market and ot...

IFRX - InflaRx Announces Public Offering of Ordinary Shares

JENA, Germany, April 11, 2023 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, announced today that it has commenced an underwritten public offeri...

IFRX - PXD, TGTX and EH among pre-market gainers

2023-04-10 08:55:07 ET OncoSec Medical ( ONCS ) +65%.GlucoTrack ( GCTK ) +29%.Guardforce AI ( GFAI ) +22%.Eloxx Pharmaceuticals ( ELOX ) +15%.Cocrystal Pharma ( COCP ) +13% on completing $4 Million private placement priced at-the-market under Nasdaq rules.Enlivex Therape...

IFRX - InflaRx Is Not Worth Chasing Following Emergency Use Authorization

2023-04-10 08:33:38 ET Summary InflaRx's Gohibic received Emergency Use Authorization (EUA) from the US FDA for treating severe COVID-19 cases. Gohibic, an anti-C5a monoclonal antibody, may reduce mortality rates and the need for renal replacement therapy in COVID-19 patients. ...

IFRX - Why InflaRx Stock Skyrocketed This Week

2023-04-07 10:21:36 ET InflaRx (NASDAQ: IFRX) stock soared this week on news that one of the company's treatments for COVID-19 had received Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA). The company's share price closed out the shortened trading week ...

IFRX - HRTX, NNVC and CDLX among mid-day movers

2023-04-06 13:25:31 ET Gainers: Guardforce AI ( GFAI ) +61% . Amesite ( AMST ) +31% . Tellurian ( TELL ) +29% . The Singing Machine Company ( MICS ) +27% . Cardlytics ( CDLX ) +22% . Finance Of America Companies ( FOA ) ...

IFRX - IFRX, LMNL and SCLX among pre-market losers

2023-04-06 08:23:15 ET Lumentum Holdings ( LITE ) -14% on lowering Q3 expectations. Scilex Holding Company ( SCLX ) -13% a nnounces p ostponement of annual meeting of stockholders. AMC Entertainment Holdings ( APE ) -12% as court rules against c...

Previous 10 Next 10